Deirdre Dimancesco
Biographic Data
| ID | 9003348 |
|---|---|
| NAME | Deirdre Dimancesco |
| GIVEN NAMES | Deirdre |
| FAMILY NAME | Dimancesco |
| SIGNATURE | DIMANCESCO D |
| AFFILIATIONS | World Health Organization |
| ORCID | 0000-0002-8783-1522 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Medicine donations
Disclosure, transparency, and accountability
BACKGROUND: Weak governance over public sector pharmaceutical policy and practice limits access to essential medicines, inflates pharmaceutical prices, and wastes scarce health system resources. Pharmaceutical systems are technically complex and involve extensive interactions between the private and public sectors. For members of public sector pharmaceutical committees, relationships with the private sector can result in conflicts of interest, wh…
The risk of corruption in public pharmaceutical procurement
Background: The goal of the public procurement of pharmaceuticals is to purchase sufficient quantities of high-quality pharmaceuticals at cost-effective prices for a given population. This goal can be undercut if corruption infiltrates the procurement process. Good procurement practices can help mitigate the risks of corruption and support equitable access to affordable and high-quality medicines.Objectives: This paper aims to 1) examine manifest…
No prominent works on this page.
The risk of corruption in public pharmaceutical procurement
Background: The goal of the public procurement of pharmaceuticals is to purchase sufficient quantities of high-quality pharmaceuticals at cost-effective prices for a given population. This goal can be undercut if corruption infiltrates the procurement process. Good procurement practices can help mitigate the risks of corruption and support equitable access to affordable and high-quality medicines.Objectives: This paper aims to 1) examine manifest…
Disclosure, transparency, and accountability
BACKGROUND: Weak governance over public sector pharmaceutical policy and practice limits access to essential medicines, inflates pharmaceutical prices, and wastes scarce health system resources. Pharmaceutical systems are technically complex and involve extensive interactions between the private and public sectors. For members of public sector pharmaceutical committees, relationships with the private sector can result in conflicts of interest, wh…
Medicine donations
Business (3 works) · Economics (3 works) · Finance (3 works) · Law (3 works) · Political science (3 works) · Accountability (2 works) · Corporate governance (2 works) · Economic growth (2 works) · Health Policy (2 works) · Marketing (2 works)